eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer

Journal:
Proceedings of the National Academy of Sciences of the United States of America
Published:
DOI:
10.1073/pnas.2424286122
Affiliations:
12
Authors:
27
Go to article
Institutions Authors Share
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)
21.000000
21.000000
21.000000
 0.78
eFFECTOR Therapeutics, Inc., United States of America (USA)
5.000000
 0.19
Weill Cornell Medicine, United States of America (USA)
0.666667
 0.02
Ludwig Institute for Cancer Research San Diego Branch, United States of America (USA)
0.333333
 0.01
Interested in Oncology and Carcinogenesis?